Both in Biotechnology
Sutro Biopharma vs Artiva Biotherapeutics
Over the past year STRO returned −2.5% and ARTV returned +17.5%; their daily moves had a correlation of 0.21.
STRO −2.5% ARTV +17.5%Growth of $1, one year, split-adjusted
| Metric | STRO | ARTV |
|---|---|---|
| Price | $9.94 | $4.22 |
| Market cap | $164.8M | $206.3M |
| Today | +4.52% | +0.48% |
| 1 month | −31.2% | −42.0% |
| 6 months | −73.6% | −65.9% |
| Year to date | −14.1% | −1.6% |
| 1 year | −9.6% | +11.9% |
| Revenue growth (YoY) | −84.6% | — |
| Gross margin | 100.0% | — |
| Net margin | −391.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.6× | — |
| Net cash | $164.3M | $349.4M |
| Dividend yield | — | — |
| Volatility (60d) | 75.3% | 92.4% |
| Short % of float | 13.1% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).